B ACUTE LYMPHOBLASTIC LEUKEMIA, PHILADELPHIA CHROMOSOME NEGATIVE
Clinical trials for B ACUTE LYMPHOBLASTIC LEUKEMIA, PHILADELPHIA CHROMOSOME NEGATIVE explained in plain language.
Never miss a new study
Get alerted when new B ACUTE LYMPHOBLASTIC LEUKEMIA, PHILADELPHIA CHROMOSOME NEGATIVE trials appear
Sign up with your email to follow new studies for B ACUTE LYMPHOBLASTIC LEUKEMIA, PHILADELPHIA CHROMOSOME NEGATIVE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Immunotherapy boosts leukemia treatment in major trial
Disease control OngoingThis large Phase 3 trial tests whether adding the immunotherapy drug blinatumomab to standard chemotherapy helps adults with a certain type of leukemia (BCR-ABL-negative B-ALL) live longer and stay cancer-free longer. About 488 newly diagnosed patients are randomly assigned to re…
Matched conditions: B ACUTE LYMPHOBLASTIC LEUKEMIA, PHILADELPHIA CHROMOSOME NEGATIVE
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 17, 2026 04:17 UTC
-
New hope for B-ALL: targeted drug added to chemo shows promise
Disease control OngoingThis study tests adding a targeted drug called tafasitamab to a standard chemotherapy regimen for adults newly diagnosed with a fast-growing blood cancer called B-ALL. The goal is to see if the combination can clear more cancer cells from the bone marrow after just one cycle of t…
Matched conditions: B ACUTE LYMPHOBLASTIC LEUKEMIA, PHILADELPHIA CHROMOSOME NEGATIVE
Phase: PHASE2 • Sponsor: University of Washington • Aim: Disease control
Last updated May 17, 2026 04:17 UTC